TCM
ADPT icon

TimesSquare Capital Management’s Adaptive Biotechnologies ADPT Stock Holding History

TimesSquare Capital Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-788,585
Closed -$10.9M – 191
2022
Q1 		$10.9M Sell
788,585
-225,600
-22% -$3.55M 0.12% 169
2021
Q4 		$28.5M Sell
1,014,185
-56,100
-5% -$1.72M 0.25% 151
2021
Q3 		$36.4M Sell
1,070,285
-9,200
-0.9% -$333K 0.32% 134
2021
Q2 		$44.1M Sell
1,079,485
-36,400
-3% -$1.42M 0.36% 123
2021
Q1 		$44.9M Sell
1,115,885
-252,178
-18% -$13.6M 0.38% 114
2020
Q4 		$80.9M Sell
1,368,063
-80,800
-6% -$4.17M 0.66% 45
2020
Q3 		$70.5M Sell
1,448,863
-126,027
-8% -$5.3M 0.66% 46
2020
Q2 		$76.2M Sell
1,574,890
-100,700
-6% -$3.67M 0.73% 41
2020
Q1 		$46.5M Buy
1,675,590
+184,709
+12% +$5.15M 0.56% 64
2019
Q4 		$44.6M Buy
1,490,881
+388,560
+35% +$11.2M 0.4% 114
2019
Q3 		$34.1M Buy
1,102,321
+651,621
+145% +$26.6M 0.3% 136
2019
Q2 		$21.8M Buy
+450,700
New +$20M 0.17% 171

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return

TimesSquare Capital Management's ADPT Position: Q2 2022 in Review

TimesSquare Capital Management sold out of Adaptive Biotechnologies (ADPT) in Q2 2022, closing a stake of 788,585 shares — an estimated $10.9M sold.

TimesSquare Capital Management first reported a position in ADPT in Q2 2019 and held it in 12 quarters. The position peaked at $80.9M in Q4 2020. 209 funds tracked by Wall St. Rank hold ADPT as of Q2 2022.

  • TimesSquare Capital Management reported no remaining Adaptive Biotechnologies position as of Q2 2022 after selling out during the quarter.
  • TimesSquare Capital Management sold 788,585 Adaptive Biotechnologies shares in Q2 2022, an estimated $10.9M.
  • TimesSquare Capital Management first reported a position in Adaptive Biotechnologies in Q2 2019 and held it in 12 quarters.
  • TimesSquare Capital Management's Adaptive Biotechnologies position peaked at $80.9M in Q4 2020.
  • 209 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2022.

Based on TimesSquare Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.